Kamil Ali-Jackson, Chief Legal Officer at Aclaris Therapeutics, Inc. (ACRS), sold 88,223 shares at $23.61 ($2.1M) on 2021-05-04, disclosed to the SEC on 2021-05-05.
Open-market sale of $2.1M ACRS by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.46 | 10,661 | $261K | 12.3% |
| 2 | $24.46 | 10,661 | $261K | 12.3% |
| 3 | $24.91 | 4,339 | $108K | 5.1% |
| 4 | $24.91 | 4,339 | $108K | 5.1% |
| 5 | $23.61 | 13,721 | $324K | 15.3% |
| 6 | $23.61 | 13,721 |
| $324K |
| 15.3% |
| 7 | $24.47 | 1,279 | $31K | 1.5% |
| 8 | $23.97 | 14,502 | $348K | 16.4% |
| 9 | $23.97 | 14,502 | $348K | 16.4% |
| 10 | $24.36 | 498 | $12K | 0.6% |
| Total | $24.08 avg | 88,223 | $2.1M | 100% |
| Filing → |
| PDSB | BUY | 2021-06-17 | $100K | — | Filing → |
| ACRS | SELL | 2021-06-04 | $417K | — | Filing → |
| ACRS | SELL | 2021-06-02 | $2.0M | — | Filing → |